Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs morphine with dexmedetomidine in HIFU ablation for uterine fibroids
ChiCTR2400081170Phase 4Not yet recruiting
- Sponsor
- Nanjing Medical University Affiliated Nanjing Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Fibromyoma (LM) comparing Oxycodone group with Morphine group (2 arms). Primary endpoints: Pain score (VAS) and Sedation score (Ramsay scale). Planned start Feb 2024; status: not yet recruiting.
02
Drugs
oxycodonemorphine
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2400081170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081170.